To Improve Adverse Event Tracking, FDA Could Google It
This article was originally published in The Rose Sheet
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.
You may also be interested in...
In an exclusive interview, new commissioner Robert Califf says FDA will tap knowledge beyond its walls, without compromising agency independence.
Research collaboration will give FDA access to individual drug safety reports from patient network’s 350,000 members and could lead to future projects on post-market surveillance.
According to FDA’s Office of Cosmetics and Colors, the number of cosmetic adverse events reported to the agency reached 491 in fiscal 2014, a 56% increase over fiscal 2013. FDA reps say the agency’s data can be deceptive and the total number likely would be higher if cosmetic adverse-event reporting were mandatory.